Range Overview References
We invite you to explore the research references from our range overview.
- Bianco L, et al. Pilot randomized controlled dosing study of cranberry capsules for reduction of bacteriuria plus pyuria in female nursing home residents. JAGS. 2012; 60(6):1180-1.
- Howell AB, et al. Dosage effect on uropathogenic Escherichia coli antiadhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis. 2010;10(1):94.
- Botto H, et al. Effectiveness of a cranberry (Vaccinium macrocarpon) preparation in reducing asymptomatic bacteriuria in patients with an ileal enterocystoplasty. Scand J Urol Nephrol. 2010;44(3):165-168.
- Lavigne J, et al. In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clin Microbiol Infect. 2008;14:350-355.
- Uberos J, et al. Cranberry syrup vs trimethoprim in the prophylaxis of recurrent urinary tract infections among children: a controlled trial. Open Access J Clin Trials 2012;4:31-386.
- Schellenberg R, et al. Dose-dependent effects of the Cimicifuga racemosa extract Ze 450 in the treatment of climacteric complaints: a randomized, placebo-controlled study. Evid Based Complement Alternat Med. 2012;(1):article ID 2603101.
- Drewe J, et al. The effect of a Cimicifuga racemosa extract Ze 450 in the treatment of climacteric complaints – an observational study. Phytomedicine. 2013;15(20):659–666.
- Lopatka L, et al. Black cohosh in the treatment of menopausal symptoms-results of an observational study with Cimifemin® uno (English translation) J für Menopause. 2007;2:3-7.
- Wesnes KA, et al. The cognitive, subjective, and physical effects of a Ginkgo biloba/Panax ginseng combination in healthy volunteers with neurasthenic complaints. Psychopharmacol Bull. 1997;33(4):677-683.
- Wesnes KA, et al. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology. 2000:152(4):353-361.
- Scholey AB, et al. Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. Hum Psychopharmacol Clin Exp. 2002;17:35-44.
- Reay JL, et al. Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. Journal of
- Kiesewetter H, et al. Hemorrheological and circulatory effects of Gincosan. Int J Clin Pharmacol Ther Toxicol. 1992;30(3):97-102.
- Forgo I, et al. The duration of effect of the standardized ginseng extract G115 in healthy competitive athletes. Notabene Med. 1985;15(9):636-40.
- Forgo I, et al. On the question of influencing the performance of top sportsmen by means of biologically active substances. Aerztl Prax. 1981;33(44):1784-1786.
- Forgo I, et al. Effect of a standardized ginseng extract on general well-being, reaction capacity, pulmonary function and gonadal hormones. Med Welt. 1981;32(19):751-756.
- Rosenfeld M, et al. Evaluation of the efficacy of a standardized ginseng extract in patients with psychophysical asthenia and neurological disorders. La Semana Medica. 1989;173(9);148-154.
- Scaglione F, et al. Efficacy and safety of the standardized Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drugs Exp Clin Res.1996; 1996;22 (2):65-72.
- Reay JL, et al. Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity’ J Psychopharmacol. 2005;19(4):357-365.
- WHO Monographs on Selected Medicinal Plants, Volume 1, Geneva, World Health Organization, 1999, 154-167 (1999) [S01 -0599].
- Ginseng: ginseng radix. European Pharmacopoeia 5.1.2005, 2935-2936. 9. Ginseng radix: ginseng. ESCOP Monographs: the Scientific Foundation for Herbal Medicinal Products, 2nd Edition, Exeter, ESCOP, 2003; 211-222 [S05-0651].
- Radix ginseng. WHO monographs on medicinal plants commonly used in the Newly Independent States (NIS). Geneva: World Health Organization, 141-159 (2010).
- Ginseng root. The Expanded Commission E Monographs, American Botanical Council 2000. Available from http://cms.herbalgram.org/expandedE/Ginsengroot.html.
- Stough C, et al. The chronic effects of an extract of Bacopa monnieri (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology. 2001:156(4);481–484.
- Stough C, et al. Examining the nootropic effects of a special extract of Bacopa monnieri on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial. Phytother Res. 2008;22(12):1629-1634.
- Downey L, et al. An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance. Phytother Res. 2013;27(9):1407-13.
- Benson S, et al. An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood. Phytother Res. 2014;28(4):551-9.
- Singh.HK. The Memory-Enhancing and Associated Effects of a Bacosides-Enriched Standardized Extract of Bacopa monniera (BESEB—CDRI-08). In Stough C. & Scholey A. (Eds.) 2013. Advances in Natural Medicines, Nutraceuticals and Neurocognition. Boca Raton: CRC Press, https://doi.org/10.1201/b13736.
- WHO monographs on selected medicinal plants Volume 2, Geneva, World Health Organization.
- Dehmlow C, et al. Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology. 1996;23(4):749-54.
- Trappoliere M, et al. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. Journal of hepatology. 2009;50(6):1102-11.
- Velussi M, et al. Long-term (23 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. Journal of hepatology. 1997;26(4):871-9.
- Schuppan D, Strosser W, Burkard G, Walosek G, 1998, Legalon® lessens fibrosing activity in patients with chronic liver diseases, Zeitschrift furAllgemeinmedizin, vol. 74, pp. 577-584.
- Albrecht, Frerick H, Kuhn U, Strenge-Hesse, 1992, The Treatment of Toxic Liver Damage with Legalon®, Clinical Pharmacology, vol. 47, no. 2, pp. 87-92.
- Buturova LI, Tsibizova TA 2010, Kalinin AV, Potential for the use of Legalon® in non-alcoholic fatty liver disease, Experimental and Clinical Gastroenterology, no. 3, pp. 85-91.
- Zhong S, Fan Y, Yan Q, Fan X, Wu B, et al. 2017, The Therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials, Medicine (Baltimore), vol. 96, no. 49, pp 1-7.
- Hashemi SJ, Hajiani E, Sardabi EH 2009, A Placebo-Controlled Trial of Silymarin in Patients with Nonalcoholic Fatty Liver Disease, Hepatitis Monthly, vol. 9, no. 4, pp. 265-270.
- Muzes G, Deak G, Lang I, Nekam K, Niederland V & Feher J 1990, Effects of Silybum (Legalon®) Treatment on the Antioxidant Defence System and Lipid Peroxidation in Patients with Chronic Alcohol Liver disease (A Double-Blind Study), Orvosi Hetilap,vol. 131, no. 16.
- Schellenberg R, et al. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ. 2001;322:134–7
- Schellenberg R, et al. Dose-dependent efficacy of the Vitex agnus-castus extract Ze 440 in patients suffering from premenstrual syndrome. Phytomedicine. 2012;19:1325– 1331 3.
- Berger D, et al. Efficacy of Vitex agnus-castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Arch Gynecol. Obstet. 2000;264:150-153.
- Koetter U, et al. A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Phytother Res 2007;21(9):847-51.
- Notter D, et al. Efficacy and safety of a valerian-hops combination-preparation in different sleep disorders, a therapy observation. Phytotherapy. 2003;3:9-13.
- Füssel A, et al. Effect of a fixed valerian-hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur J Med Res. 2000;5:385–90.
- Lataster MJ, et al. The treatment of patients with sleep disorders. Notabene Medici. 1996;4:182.
- Brattström A. Scientific evidence for a fixed extract combination (Ze 91019) from valerian and hops traditionally used as a sleep-inducing aid. Wien Med Wochenschr. 2007;157(13-14):367-70.
- Morin CM, et al. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep. 2005 Nov 1;28(11):1465-71.
- Brattstrom A. Long-term effects of St. John’s wort (Hypericum perforatum) treatment: A 1-year safety study in mild to moderate depression. Phytomedicine 2009;16:277-83.
- Schrader E. Equivalence of St John’s wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol. 2000;15:61-8.
- Woelk H. Comparison of St John’s wort and imipramine for treating depression: a randomized controlled trial. BMJ 2000;321:536-9.
- Schrader E, et al. Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study. Hum Psychopharmacol 1998;13(3):163–9.
- Ruedeberg C, et al. Hypericum perforatum L.(St John’s wort) extract Ze 117 inhibits dopamine re-uptake in rat striatal brain slices. An implication for use in smoking cessation treatment? Phytother Res. 2010;24(2):249-51.
- Kientsch U, et al. St. John’s wort extract Ze 117 (Hypericum perforatum) inhibits norepinephrine and serotonin uptake into rat brain slices and reduces β-adrenoceptor numbers on cultured rat brain cells. Pharmacopsychiatry. 2001;34(Sup.1):56-60.
- Schuchardt J, et al. Intestinal absorption and factors influencing bioavailability of magnesium-an update. Current Nutrition & Food Science. 2017;13(4):260-78.
- Jeon SH, et al. Taurine increases cell proliferation and generates an increase in [Mg2+] i accompanied by ERK 1/2 activation in human osteoblast cells. FEBS letters. 2007 Dec 22;581(30):5929-34.
- Head KA. Taurine-monograph. Alt Med Rev. 2001;6(1):78-82.
- Magnesium. 2014.Nutrient reference values for Australia and New Zealand. Available from: https://www.nrv.gov.au/nutrients/magnesium
We invite you to explore the research further by registering or logging into our health professional website >